Melissa C. Kapulu

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa.

Widespread variants of the highly polymorphic Plasmodium falciparum vaccine candidate antigen MSP2 across Sub-Saharan Africa.

Journal: The Journal of infectious diseases

Published: February 17, 2026

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

Journal: Frontiers in immunology

Published: November 10, 2025

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.

Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons.

Journal: Frontiers in immunology

Published: July 25, 2025

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

Journal: Frontiers in immunology

Published: April 29, 2025

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.

Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.

Journal: Frontiers in immunology

Published: April 29, 2025

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.

Baseline Treg frequency, Treg-associated immune checkpoint responses, and plasma IL-10 responses during controlled human malaria infection in semi-immune Kenyan adults: a secondary analysis of the CHMI-SIKA Study.

Journal: The Lancet. Microbe

Published: April 22, 2025

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella.

Protein-specific immune response elicited by the Shigella sonnei 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to Shigella.

Journal: mSphere

Published: April 16, 2025

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Journal: Nature medicine

Published: January 20, 2025

Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes.

Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes.

Journal: PLoS pathogens

Published: August 30, 2024

Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.

Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.

Journal: The Journal of infection

Published: June 12, 2024

Reversible host cell surface remodelling limits immune recognition and maximizes transmission of Plasmodium falciparum gametocytes.

Reversible host cell surface remodelling limits immune recognition and maximizes transmission of Plasmodium falciparum gametocytes.

Journal: bioRxiv : the preprint server for biology

Published: May 15, 2024

Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.

Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.

Journal: Immunity

Published: January 30, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026